DOD Biotech PCL (BKK:DOD)

DOD Biotech PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	617.37	645.38	663.61	537.16	1,015	1,077
Other Revenue	15.31	16.65	29.09	11.17	3.03	2.59
Revenue	632.68	662.04	692.71	548.33	1,018	1,080
Revenue Growth (YoY)	-8.48%	-4.43%	26.33%	-46.16%	-5.70%	35.68%
Cost of Revenue	405.27	438.58	406.36	396.66	580.7	616.39
Gross Profit	227.4	223.46	286.35	151.68	437.65	463.53
Selling, General & Admin	184.91	209	198.52	163.05	126.84	106.7
Operating Expenses	184.91	209	198.52	163.05	128.35	106.7
Operating Income	42.49	14.46	87.84	-11.38	309.3	356.82
Interest Expense	-2.59	-3.73	-5.31	-7.09	-6.72	-6.85
Interest & Investment Income	1.78	0.73	0.25	0.11	0.25	0.22
EBT Excluding Unusual Items	41.67	11.46	82.78	-18.36	302.84	350.19
Gain (Loss) on Sale of Investments	-0.47	29.03	10.04	-405.86	15.45	-25.55
Asset Writedown	-	-	-	-	-53.23	-
Pretax Income	41.2	40.49	92.82	-424.23	265.06	324.64
Income Tax Expense	11.09	13.32	28.3	-79.11	31.96	33.87
Earnings From Continuing Operations	30.11	27.17	64.51	-345.12	233.1	290.77
Earnings From Discontinued Operations	16.35	-190.99	-50.94	-55.37	-187.44	-138.74
Net Income to Company	46.46	-163.82	13.57	-400.49	45.66	152.03
Minority Interest in Earnings	4.52	4.48	-6.39	2.15	4.12	-10.79
Net Income	50.99	-159.33	7.19	-398.33	49.79	141.25
Net Income to Common	50.99	-159.33	7.19	-398.33	49.79	141.25
Net Income Growth	-	-	-	-	-64.75%	62.90%
Shares Outstanding (Basic)	450	450	435	410	410	410
Shares Outstanding (Diluted)	450	450	435	410	410	410
Shares Change (YoY)	-0.01%	3.47%	6.17%	-	-	-
EPS (Basic)	0.11	-0.35	0.02	-0.97	0.12	0.34
EPS (Diluted)	0.11	-0.35	0.02	-0.97	0.12	0.34
EPS Growth	-	-	-	-	-64.45%	62.67%
Free Cash Flow	61.81	12.31	4.72	-194	-37.93	194.64
Free Cash Flow Per Share	0.14	0.03	0.01	-0.47	-0.09	0.47
Gross Margin	35.94%	33.75%	41.34%	27.66%	42.98%	42.92%
Operating Margin	6.72%	2.18%	12.68%	-2.08%	30.37%	33.04%
Profit Margin	8.06%	-24.07%	1.04%	-72.65%	4.89%	13.08%
Free Cash Flow Margin	9.77%	1.86%	0.68%	-35.38%	-3.72%	18.02%
EBITDA	81.04	71.39	156.11	48.03	371.45	427.02
EBITDA Margin	12.81%	10.78%	22.54%	8.76%	36.48%	39.54%
D&A For EBITDA	38.55	56.93	68.27	59.41	62.15	70.2
EBIT	42.49	14.46	87.84	-11.38	309.3	356.82
EBIT Margin	6.72%	2.18%	12.68%	-2.08%	30.37%	33.04%
Effective Tax Rate	26.91%	32.89%	30.49%	-	12.06%	10.43%
Revenue as Reported	632.68	662.04	692.71	548.33	1,018	1,080

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.